Detailed association between serum uric acid levels and the incidence of chronic kidney disease stratified by sex in middle-aged adults
Graphical abstract
Introduction
Chronic kidney disease (CKD) is a major global health burden. Globally, CKD incidence, and disability and death due to CKD have been increasing [1]. According to previous studies, serum uric acid (SUA) levels have shown a J- or U-shaped association with all-cause and cardiovascular mortality [2,3].
With regard to the association of SUA with the kidney, high SUA levels may serve as an independent risk factor for CKD [[4], [5], [6], [7], [8], [9], [10], [11]]. Although high SUA levels may be involved in CKD incidence in middle-aged individuals, there is little evidence regarding the association between SUA and CKD incidence in this population. Some studies have indicated a possible association between SUA levels and CKD risk in cohorts with a mean age between 40 and 50 years. Participants in these cohort studies were categorized broadly according to their SUA levels and the CKD risk of the group with SUA ≥7 mg/dL was not clear [7,9,10]. Moreover, in these studies, the CKD incidence was defined using only the eGFR (estimated glomerular filtration rate) levels. Nonetheless, in the Hisayama study, based on 2059 participants, which investigated the influence of SUA levels on the incidence of kidney dysfunction and albuminuria in the general Japanese population, the mean age was 59 years [4]. Precise evidence regarding the association between high SUA levels and CKD risk can contribute to early CKD prevention in middle-aged individuals.
Sex and baseline eGFR can also be strong confounding factors for the association between SUA and the risk of CKD incidence. Women have lower SUA levels than men because estrogen stimulates urinary urate excretion [12,13]. Hence, SUA levels and CKD incidence may be different between men and women.
Uric acid, a purine metabolism product, is reabsorbed and excreted in the renal proximal tubule after being filtered. Patients with CKD have decreased uric acid urinary excretion and elevated SUA levels [14]. While the inclusion of participants with eGFR close to 60 mL/min/1.73 m2 in the evaluation of the association between SUA levels and CKD incidence could lead to reverse causality, all previous studies included these individuals and only adjusted the results for baseline eGFR levels [[4], [5], [6], [7], [8], [9]].
We, therefore, examined the association between SUA levels and CKD incidence in middle-aged adults stratified by sex, based on a longitudinal analysis with multiple measurements of serum creatinine (SCr) acquired from a large-scale health checkup of a general Asian population. Then, we excluded participants with eGFR <70 mL/min/1.73 m2 due to their extremely high risk of CKD incidence [15]. Furthermore, we also assessed the association between low SUA levels and elevated risk of CKD incidence since this piece of information in middle-aged Asian individuals had been scarce [8,9].
Section snippets
Data source
Data for this retrospective cohort study were retrieved from the commercially available JMDC Inc. (Tokyo, Japan) administrative claims database. The database includes annual health checkup data from Japanese employees and their employees <75 years old, who are enrolled in health insurance plans offered by large companies [[15], [16], [17]]. Individuals ≥75 years old are not included in this database because they are covered by the public health insurance system (the medical care system for the
Baseline characteristics
The mean participant age was 44.1 years, and 29.6% of the participants were women. The mean SUA level was 5.9 mg/dL in men and 4.1 mg/dL in women. The number of participants with SUA levels ≥9.0 mg/dL was 810 (0.83%) in men and 6 (0.015%) in women.
Table 1 shows the participants' characteristics based on SUA levels in men and women. The proportion of dyslipidemia and the mean age of participants was associated positively and inversely, respectively, with men's SUA levels. The prevalence of
Discussion
This longitudinal study demonstrated that the risk of CKD incidence or proteinuria increased in individuals with SUA <4.0 and ≥ 10.0 mg/dL in men, and <4.0 and ≥ 7.0 mg/dL in women, compared to those with SUA 4.0–4.9 mg/dL, after adjustment for various covariates (Fig. 2, Fig. 3 and Supplementary Table S7). The present study also indicated that both low and high SUA levels could be associated with the risk of CKD incidence in Asian middle-aged men and women.
We indicated for the first time the
Financial support
This study was supported by Grants for Scientific Research (17K15853, 17K19930, 20K08612 and 21K10478) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; academic contributions from Pfizer Japan Inc., Japan; scholarship donations from Chugai Pharmaceutical Co., Ltd., Japan, and Daiichi Sankyo Co., Ltd., Japan; research supports from Astellas Pharma Inc., Japan, Takeda Pharmaceutical Co., Ltd., Japan, and Bayer Yakuhin Co., Ltd., Japan; the Health Care Science
CRediT authorship contribution statement
Shingo Nakayama: Conceptualization, Methodology, Formal analysis, Validation, Writing – original draft, Visualization. Michihiro Satoh: Conceptualization, Methodology, Resources, Data curation, Writing – review & editing, Supervision, Project administration, Funding acquisition. Yukako Tatsumi: Conceptualization, Methodology, Formal analysis, Writing – review & editing. Takahisa Murakami: Methodology, Writing – review & editing. Tomoko Muroya: Methodology, Writing – review & editing. Takuo
Declaration of competing interest
T.O. and H.M. concurrently held the position of director of the Tohoku Institute for Management of Blood Pressure, which was supported by Omron Healthcare Co., Ltd. The Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University received scholarship donations for education from Baxter Co., Ltd., and Otsuka Pharmaceutical Co., Ltd. The Division of Nephrology and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical
Acknowledgements
We are grateful to all the staff at JMDC Inc.
References (31)
- et al.
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
Kidney Int.
(2018) - et al.
Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies
BMC Nephrol.
(2014) - et al.
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
Am. J. Kidney Dis.
(2006) - et al.
Revised equations for estimated GFR from serum creatinine in Japan
Am. J. Kidney Dis.
(2009) - et al.
Alterations of renal function during dietary-induced hyperuricemia in the rat
Kidney Int.
(1976) - et al.
Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats
Kidney Int.
(2005) - et al.
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD
Am. J. Kidney Dis.
(2014) - et al.
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study
Kidney Int.
(2007) - et al.
Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality
Rheumatology
(2013) - et al.
Association between serum uric acid levels and mortality: a nationwide community-based cohort study
Sci. Rep.
(2020)
Serum uric acid as a risk factor for chronic kidney disease in a Japanese community- the Hisayama study
Circ. J.
Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies
PloS One
Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan
Nephrology
Effect of uric acid on the development of chronic kidney disease: the Korean multi-rural communities cohort study
J Prev Med Public Health
U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2
Hypertens. Res.
Cited by (7)
Dysuricemia
2023, BiomedicinesSerum Uric Acid Levels and Their Association with Renal Function Decline and Kidney Disease Progression in Middle-Aged and Elderly Populations: A Retrospective Cohort Study
2023, Journal of Multidisciplinary Healthcare